Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization

BACKGROUND: The inclusion of immune checkpoint inhibitors (ICIs) in therapeutic algorithms has led to significant survival benefits in patients with various metastatic cancers. Concurrently, an increasing number of neurological immune related adverse events (IRAE) has been observed. In this retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Urban, Hans, Steidl, Eike, Hattingen, Elke, Filipski, Katharina, Meissner, Markus, Sebastian, Martin, Koch, Agnes, Strzelczyk, Adam, Forster, Marie-Thérèse, Baumgarten, Peter, Ronellenfitsch, Michael W., Steinbach, Joachim P., Voss, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761630/
https://www.ncbi.nlm.nih.gov/pubmed/35046955
http://dx.doi.org/10.3389/fimmu.2021.798811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761630/
https://www.ncbi.nlm.nih.gov/pubmed/35046955
http://dx.doi.org/10.3389/fimmu.2021.798811

Ejemplares similares